Trial Profile
An open label, randomized, multi-center, phase IIIB, parallel group switching study to compare the efficacy and safety of lipid lowering agents atorvastatin and simvastatin with rosuvastatin in high risk subjects with type IIA and IIB hypercholesterolemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Apr 2008
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Atorvastatin; Simvastatin
- Indications Hyperlipoproteinaemia type II; Hypertriglyceridaemia
- Focus Therapeutic Use
- Acronyms MERCURY-II
- Sponsors AstraZeneca
- 30 Apr 2008 New trial record.